Northwestern Medicine

Exo® Launches FDA-Cleared AI on Exo Iris™ to Address Heart Failure

Retrieved on: 
星期二, 四月 23, 2024

The number of Americans with heart failure today is over 6.7 million and growing.

Key Points: 
  • The number of Americans with heart failure today is over 6.7 million and growing.
  • While echocardiography is the cornerstone of heart failure diagnosis, it is costly and requires highly trained sonographers to use it.
  • Exo’s revolutionary ecosystem includes Exo Iris, as well as a fast-growing suite of AI solutions and its award-winning POCUS workflow software, Exo Works® .
  • To purchase Exo Iris and the rest of Exo’s medical imaging ecosystem, visit Exo’s website or contact us to learn more.

Agitated Solutions Receives Health Canada License for Orbis Microbubble Generator to Streamline Cardiac Bubble Studies

Retrieved on: 
星期四, 四月 18, 2024

Agitated Solutions, Incorporated (ASI) announced today that it has been issued a Medical Device Establishment License (MDEL) from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies.

Key Points: 
  • Agitated Solutions, Incorporated (ASI) announced today that it has been issued a Medical Device Establishment License (MDEL) from Health Canada for its innovative Orbis™ Microbubble Generator that simplifies and streamlines the process of saline agitation and delivery for cardiac bubble studies.
  • View the full release here: https://www.businesswire.com/news/home/20240418247093/en/
    The Orbis™ Microbubble Generator is the first tool to automatically agitate the saline with uniform, small bubbles that endure longer for visibility.
  • The standard of care for cardiac bubble studies requires one clinician to conduct the imaging while a second clinician agitates and injects the saline.
  • Immediately following receipt of the Health Canada license, the first clinical use of Orbis was conducted at University Health Network (UHN) Toronto General Hospital in Toronto, Canada.

Brooke Eby, ALS Patient and Advocate, to deliver Keynote Address at 2024 MDA Clinical & Scientific Conference

Retrieved on: 
星期四, 二月 15, 2024

New York, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Brooke Eby will be the keynote speaker at the 2024 MDA Clinical & Scientific Conference (being held in Orlando, FL March 3-6), where she will address the world’s leaders in neuromuscular disease research and care.

Key Points: 
  • New York, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Brooke Eby will be the keynote speaker at the 2024 MDA Clinical & Scientific Conference (being held in Orlando, FL March 3-6), where she will address the world’s leaders in neuromuscular disease research and care.
  • As the largest US gathering focused solely on neuromuscular diseases including ALS, the 2024 MDA Clinical & Scientific Conference promises to delve into the latest research advancements and clinical achievements in the field.
  • "We are honored to have Brooke Eby grace our conference to share her story and insights as a patient and as a patient advocate," remarked Sharon Hesterlee, Ph.D., Chief Research Officer, MDA.
  • Members of the neuromuscular community who are registered with MDA are welcome to participate in the virtual conference at no-cost.

Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. Hospitals

Retrieved on: 
星期四, 十二月 14, 2023

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV) bag recycling program pilot.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV) bag recycling program pilot.
  • View the full release here: https://www.businesswire.com/news/home/20231214638041/en/
    Photo of IV bag recycling provided by Northwestern Medicine.
  • All IV bags involved in this pilot were made of PVC, one of the most widely used plastic materials in medical products.
  • In recent years, Baxter has introduced several programs to facilitate recycling for patients and hospitals in Australia, New Zealand, Guatemala and Colombia.

Hubly Drill Used in Life-Saving Bedside Procedures

Retrieved on: 
星期四, 十一月 2, 2023

Dr. Matthew Potts, Associate Professor of Neurosurgery, Neurology, and Radiology at Northwestern Medicine, performed the very first successful procedure with Hubly Drill.

Key Points: 
  • Dr. Matthew Potts, Associate Professor of Neurosurgery, Neurology, and Radiology at Northwestern Medicine, performed the very first successful procedure with Hubly Drill.
  • "This drill is faster and easier to use than the standard hand-powered drills currently used for emergent bedside procedures," said Dr. Potts, after drilling the hole in 16 seconds—far faster than the average for a hand-crank drill.
  • Dr. Sabih Effendi, neurosurgeon and Stroke Medical Director in the Greater Houston area, used Hubly Drill mere hours later.
  • Hubly is the first bedside-ICU neurosurgical drill suitable for this millennium."

Strata’s User Conference Mobilizes Over 2,400 Healthcare Leaders to Address Industry’s Most Pressing Financial Challenges

Retrieved on: 
星期三, 十月 25, 2023

The LIFT23 event highlights use cases and best practices for addressing the challenges facing healthcare provider organizations today, offering leadership panels, product demonstrations and industry thought leadership.

Key Points: 
  • The LIFT23 event highlights use cases and best practices for addressing the challenges facing healthcare provider organizations today, offering leadership panels, product demonstrations and industry thought leadership.
  • This year’s event offered new tools and resources to tackle today’s industry challenges, including new data & intelligence solutions, lessons and insights from LEAP Award winners and peer-led CPE-accredited panels and sessions.
  • "Our healthcare clients are facing a number of challenges, including workforce shortages, new competition, shifts in care settings and other margin pressures,” said John Martino, Strata’s Chief Executive Officer.
  • This extended report combines financial, operational, and claims data from hospitals and physician practices across the country.

Data Presented at UEG Week 2023 Further Support the Potential of Celltrion’s Investigational Subcutaneous Infliximab CT-P13 SC in the Treatment of Inflammatory Bowel Disease

Retrieved on: 
星期一, 十月 16, 2023

The proportion of patients who experienced adverse events (AEs), serious AEs, infection in the SC infliximab and placebo groups were generally comparable.

Key Points: 
  • The proportion of patients who experienced adverse events (AEs), serious AEs, infection in the SC infliximab and placebo groups were generally comparable.
  • If approved by the FDA, CT-P13 SC would be the first subcutaneous formulation of infliximab.
  • Post-hoc analyses of the LIBERTY-CD and LIBERTY-UC studies were presented as posters at UEG Week 2023.
  • The first post-hoc analysis examined the possible use of SC infliximab treatment without immunosuppressants and the second evaluated dose escalation in patients with loss of treatment response.

Bizz Energy Is a Clean, Mean Way to Beat the Modern Midday Slump

Retrieved on: 
星期四, 十月 5, 2023

FORT LAUDERDALE, Fla., Oct. 5, 2023 /PRNewswire/ -- The modern, remote-first work world may not have a consistent nine-to-five rhythm anymore. But that doesn't change the fact that people are still putting a lot of time into working their jobs. The Bureau of Labor Statistics reports that the average American worker clocks in at just over eight hours of labor per day (8.01, to be precise). That means, no matter when those work hours take place, they're going to extend over a significant portion of an individual's daily schedule. It also means it will involve a slump in energy and productivity at some point along the way.

Key Points: 
  • It also means it will involve a slump in energy and productivity at some point along the way.
  • "Midday slumps may not always happen in the early afternoon anymore," says Gavin Jacono, founder of Bizz Energy, "But they happen at some point — and on a regular basis.
  • Northwestern Medicine points out that the biggest reason for this energy slump is that it's a predictable part of every individual's circadian cycle.
  • This makes it a clean, mean way to beat a midday slump — no matter when it might take place.

TapestryHealth Names Liz Kirk Chief Operating Officer

Retrieved on: 
星期二, 九月 26, 2023

STRATFORD, Conn., Sept. 26, 2023 /PRNewswire/ -- TapestryHealth, a leading health risk management platform that continuously assesses, monitors and accelerates clinical care interventions to chronically ill, medically underserved seniors in long term care settings announced today that Liz Kirk will become Chief Operating Officer. Prior to joining TapestryHealth, Liz was Senior Vice President of Strategic Services at Strata Decision Technology where she led the scaling and expansion of delivery operations as the company grew over twenty-five times during her ten-year tenure.

Key Points: 
  • STRATFORD, Conn., Sept. 26, 2023 /PRNewswire/ -- TapestryHealth, a leading health risk management platform that continuously assesses, monitors and accelerates clinical care interventions to chronically ill, medically underserved seniors in long term care settings announced today that Liz Kirk will become Chief Operating Officer.
  • Prior to joining TapestryHealth, Liz was Senior Vice President of Strategic Services at Strata Decision Technology where she led the scaling and expansion of delivery operations as the company grew over twenty-five times during her ten-year tenure.
  • "Liz is a seasoned leader in health tech and healthcare delivery who consistently delivers financial results by leveraging technology, building high performing teams and streamlining costs," said Mark Hirschhorn, TapestryHealth CEO.
  • "I'm delighted to join TapestryHealth and work towards improving one of the most challenging and under-served elements of the continuum of care," said Ms. Kirk.

Cardiosense Begins Enrollment in Nationwide Heart Failure Study

Retrieved on: 
星期二, 九月 26, 2023

CHICAGO, Sept. 26, 2023 /PRNewswire/ -- Cardiosense, a digital health company developing a non-invasive monitoring platform for the early detection of heart disease, recently started enrolling patients in SEISMIC-HF I, its nationwide clinical study to refine and validate algorithms to assess intracardiac filling pressure, an early physiological marker for acute heart failure decompensation. The algorithms leverage data captured by CardioTag, Cardiosense's non-invasive patch that measures key parameters of cardiac function. Cardiosense was awarded FDA Breakthrough Device Designation in 2022.

Key Points: 
  • CHICAGO, Sept. 26, 2023 /PRNewswire/ -- Cardiosense, a digital health company developing a non-invasive monitoring platform for the early detection of heart disease, recently started enrolling patients in SEISMIC-HF I, its nationwide clinical study to refine and validate algorithms to assess intracardiac filling pressure, an early physiological marker for acute heart failure decompensation.
  • Heart failure affects more than 6 million people in the US and is expected to cost the healthcare system more than $70 billion annually by 2030.
  • "Cardiosense's technology has the potential to be a game-changing solution in remotely monitoring patients with heart failure.
  • I'm excited to participate in the SEISMIC-HF I study and that Northwestern Medicine was the first site to enroll patients."